Cistofuran en es it fr

Categoria

Cistofuran Marchi, Cistofuran Analoghi

Cistofuran Marchi miscela

  • No information avaliable
  • Cistofuran Formula chimica

    C8H6N4O5

    Cistofuran RX link

    http://www.rxlist.com/cgi/generic/nitro25m.htm

    Cistofuran FDA foglio

    Cistofuran DMS (foglio di materiale di sicurezza)

    Cistofuran MSDS

    Cistofuran Sintesi di riferimento

    Nessuna informazione disponibile

    Cistofuran Peso molecolare

    238.157 g/mol

    Cistofuran Temperatura di fusione

    263 oC

    Cistofuran H2O Solubilita

    79,5 mg / L

    Cistofuran Stato

    Solid

    Cistofuran LogP

    -0.04

    Cistofuran Forme di dosaggio

    Compressa

    Cistofuran Indicazione

    Per il trattamento delle infezioni del tratto urinario

    Cistofuran Farmacologia

    Nitrofurantoina, un agente antibatterico nitrofurano, รจ disponibile in forma microcristallina e macrocrystalline nel trattamento delle infezioni del tratto urinario causata da molti batteri gram-negativi e alcuni batteri gram-positivi.

    Cistofuran Assorbimento

    Nessuna informazione disponibile

    Cistofuran Tossicita

    Nessuna informazione disponibile

    Cistofuran Informazioni paziente

    Patients should be advised to take Macrobid with food (ideally breakfast and dinner) to further enhance tolerance and improve drug absorption. Patients should be instructed to complete the full course of therapy; however, they should be advised to contact their physician if any unusual symptoms occur during therapy.

    Patients should be advised not to use antacid preparations containing magnesium trisilicate while taking Macrobid.

    Patients should be counseled that antibacterial drugs including Macrobid should only be used to treat bacterial infections. They do not treat viral infections (e.g., the common cold). When Macrobid is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and will not be treatable by Macrobid or other antibacterial drugs in the future.

    Cistofuran Atto interessato organismi

    Gram negativi e alcuni batteri gram-positivi